Medicines authorised during pandemic

30 November 2025

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes

26 November 2025

European Medicines Agency post-authorisation procedural advice for users of the centralised procedure

26 November 2025

Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 2, Status: Authorised

25 November 2025

Withdrawn application: Vectra 3D, 27/11/2024

25 November 2025

Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn

25 November 2025

Human medicines European public assessment report (EPAR): Exjade, deferasirox, Date of authorisation: 28/08/2006, Revision: 56, Status: Authorised

25 November 2025

2009 (H1N1) influenza pandemic

25 November 2025

Pandemic influenza

25 November 2025

Vaccines for pandemic influenza

25 November 2025